Hassebroek AM, Sooryanarain H, Lynn Heffron C, Hawks SA, et al. A hepatitis B virus core antigen-based virus-like particle vaccine expressing SARS-CoV-2 B and T cell epitopes induces epitope-specific humoral and cell-mediated immune responses but confers limited protection against SARS-CoV-2 infection. J Med Virol 2023 Jan 19. doi: 10.1002/jmv.28503.
PMID: 36655751